Terns Pharmaceuticals (TERN) Debt to Equity (2020)
Terns Pharmaceuticals filings provide 1 years of Debt to Equity readings, the most recent being -$0.11 for Q4 2020.
- Quarterly Debt to Equity changed N/A to -$0.11 in Q4 2020 from the year-ago period, while the trailing twelve-month figure was -$0.11 through Dec 2020, changed N/A year-over-year, with the annual reading at -$0.11 for FY2020, N/A changed from the prior year.
- Debt to Equity hit -$0.11 in Q4 2020 for Terns Pharmaceuticals.
- Across five years, Debt to Equity topped out at -$0.11 in Q4 2020 and bottomed at -$0.11 in Q4 2020.